Hyperion Defi (HYPD) Income from Continuing Operations (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Income from Continuing Operations of 8750417.0 for Q1 2026, up 344.64% year-over-year from 1967974.41 in Q1 2025, and up 121.4% quarter-over-quarter from 40888858.0 in Q4 2025.
Hyperion Defi (HYPD) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Income from Continuing Operations for 10 consecutive years, with 8750417.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 344.64% year-over-year to 8750417.0; the TTM figure through Mar 2026 stood at 36749231.0 (up 19.9% YoY), while the FY2025 annual figure was 96311559.0, down 88.96% from the prior year.
- Income from Continuing Operations rose to 8750417.0 in Q1 2026 per HYPD's latest filing, from 40888858.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 8750417.0 in Q1 2026 and bottomed at 40888858.0 in Q4 2025.
- Historically, Income from Continuing Operations has averaged 8884859.24 across 5 years, with a median of 7407366.0 in 2022.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations tumbled 277.34% — and 2026, when it jumped 344.64%.
- Hyperion Defi's Income from Continuing Operations stood at 5085981.0 in 2022, then plunged by 56.03% to 7935815.0 in 2023, then plunged by 151.29% to 19942005.0 in 2024, then plunged by 105.04% to 40888858.0 in 2025, then surged by 121.4% to 8750417.0 in 2026.
- Business Quant data shows HYPD's Income from Continuing Operations at 8750417.0 in Q1 2026, 40888858.0 in Q4 2025, and 4248969.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 164.49 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -13.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -174.37 Mn |
| 10 | Hyperion Defi | 44.65 Mn | 35.01 Mn | 357,693.00 | 30.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.98 Mn |
| Mar 31, 2026 | 8.75 Mn |
| Dec 31, 2025 | -40.89 Mn |
| Sep 30, 2025 | 4.25 Mn |
| Jun 30, 2025 | -8.86 Mn |
| Mar 31, 2025 | -3.58 Mn |
| Dec 31, 2024 | -19.94 Mn |
| Sep 30, 2024 | -8.92 Mn |
| Jun 30, 2024 | -13.44 Mn |
| Mar 31, 2024 | -12.14 Mn |
| Dec 31, 2023 | -7.94 Mn |
| Sep 30, 2023 | -6.99 Mn |
| Jun 30, 2023 | -8.33 Mn |
| Mar 31, 2023 | -5.91 Mn |
| Dec 31, 2022 | -5.09 Mn |
| Sep 30, 2022 | -7.41 Mn |
| Jun 30, 2022 | -7.27 Mn |
| Mar 31, 2022 | -7.33 Mn |
| Dec 31, 2021 | 2.87 Mn |
| Sep 30, 2021 | -6.04 Mn |